News & Insights

Praedicat in the news.

Read what we think and what others think, all meant to make you think.

Praedicat Posts on Scenarios

Praedicat Press Release – Convex Partners with Praedicat
Praedicat Press Release – Convex Partners with Praedicat 700 350 Meghan Dengler

February 3, 2021: Convex announces partnership with Praedicat  Praedicat is thrilled that Convex, the international specialty insurer and reinsurer has licensed our products to help Convex identify, underwrite and manage…

read more

Praedicat’s Lloyd’s Lab Spotlight
Praedicat’s Lloyd’s Lab Spotlight 938 438 Bob Reville

Praedicat Lloyd’s Lab Spotlight: In case you missed the Lloyd’s Lab Spotlight Presentation previewing some of Praedicat’s work as part of Cohort 5, you can watch the full video here.…

read more

Praedicat Featured in Carrier Management, ExecTalk
Praedicat Featured in Carrier Management, ExecTalk 150 150 Bob Reville

Praedicat Featured in new Carrier Management video series, ExecTalk As part of Carrier Management’s new video series, ExecTalk, Praedicat’s Bob Reville and Adam Grossman give a glimpse of the 9…

read more

Praedicat Webinar: Risk Management Moving Forward
Praedicat Webinar: Risk Management Moving Forward 150 150 Bob Reville

 Before viewing the webinar, please take a moment to join our mailing list by filling out the short form in the video window. Once you are finished watching the…

read more

Praedicat Press Release – Hiscox Partners with Praedicat
Praedicat Press Release – Hiscox Partners with Praedicat 750 350 Meghan Dengler

July 13th, 2020: Hiscox announces partnership with Praedicat Praedicat is thrilled that Hiscox, the specialist global insurer, has licensed our products CoMeta® and Oortfolio®, for use within its London Market…

read more

Praedicat Launches COVID-19 Litigation Tracker
Praedicat Launches COVID-19 Litigation Tracker 1280 450 Meghan Dengler

June 25th, 2020: Praedicat announces the launch of our unprecedented COVID-19 Litigation Tracker Praedicat is proud to introduce our new Litigation Tracker, which monitors emerging SARS-CoV-2 litigation complaint by complaint.…

read more

Coffee with Bob: The Pandemic Behind the Pandemic
Coffee with Bob: The Pandemic Behind the Pandemic 150 150 Bob Reville

Before viewing the webinar, please take a moment to join our mailing list by filling out the short form in the video window. . Once you are finished watching the…

read more

Praedicat Press Release – COVID-19 Scenarios
Praedicat Press Release – COVID-19 Scenarios 750 350 Meghan Dengler

June 8th, 2020: Praedicat announces the launch of a scenario-based COVID-19 exposure modeling program. . Praedicat has developed scenarios that represent a range of ultimate pandemic outcomes, including fully-specified causes…

read more

Praedicat Launches COVID-19 Scenarios
Praedicat Launches COVID-19 Scenarios 750 350 Meghan Dengler

Praedicat announces the launch of COVID-19 litigation scenarios Millions worldwide have been infected with the novel coronavirus SARS-CoV-2 and sickened by the respiratory illness COVID-19. The epidemiological and economic course…

read more

Coffee with Bob: Scenarios for Large-Scale COVID-19 Litigation
Coffee with Bob: Scenarios for Large-Scale COVID-19 Litigation 150 150 Bob Reville

Before viewing the webinar, please take a moment to join our mailing list by filling out the short form below. Once you are finished watching, please take a brief 5-minute…

read more

Insurance ERM: Praedicat Scenario Tool Targets COVID-19 Litigation Assessments
Insurance ERM: Praedicat Scenario Tool Targets COVID-19 Litigation Assessments 750 350 Meghan Dengler

April 29th: In an article published by Insurance ERM, Praedicat scenario tool targets Covid-19 litigation assessments, Robert Reville, Praedicat CEO, discusses the upcoming launch of a suite of tools to…

read more

Personal exposure monitoring could be the next driver of litigation
Personal exposure monitoring could be the next driver of litigation 500 333 Adam Grossman

One of the main impediments to understanding environmental drivers of disease is having an accurate assessment of exposure.  This article shows why this barrier is beginning to vanish by detailing…

read more
  • 1
  • 2
Start Typing